Related Experiment Videos
[Light chain disease with terminal myocardiopathy]
Archives Des Maladies Du Coeur Et Des Vaisseaux
|June 1, 1985
Summary
This case study highlights light chain deposition disease, a rare condition causing congestive cardiac failure due to intramyocardial immunoglobulin deposits. Early detection using immunofluorescence is crucial for this poorly understood disease with a poor prognosis.
Area of Science:
- Cardiology
- Nephrology
- Hematology
Background:
- Light chain deposition disease (LCDD) is a rare systemic disorder characterized by the infiltration of monoclonal light chains into various organs.
- Cardiac involvement in LCDD, while increasingly recognized, often presents insidiously and can lead to significant morbidity and mortality.
- Accurate diagnosis and understanding the full spectrum of organ involvement are critical for managing this complex condition.
Observation:
- A 35-year-old male presented with congestive cardiac failure.
- Echocardiography revealed diffuse hypokinetic wall motion and moderate parietal hypertrophy without cardiac dilatation.
- Post-mortem examination confirmed intramyocardial light chain deposits, consistent with findings in renal and liver biopsies.
Findings:
- The patient's condition was attributed to polyvisceral infiltrations of light chain monoclonal immunoglobulins.
- Renal disease is typically the primary manifestation, often progressing to renal failure.
- Cardiac involvement, though less commonly the primary focus, is a significant and potentially life-threatening complication.
Implications:
- The study underscores the importance of considering light chain deposition disease in cases of unexplained cardiac dysfunction, especially when accompanied by renal or liver abnormalities.
- Monoclonal plasmocytic proliferation, often associated with myeloma, is a hallmark of LCDD, though not always malignant.
- The incidence of cardiac involvement in LCDD may be underestimated, suggesting a need for increased awareness and utilization of immunofluorescent techniques for diagnosis, potentially revealing it to be more common than amyloidosis.